These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31361762)

  • 1. The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington's disease.
    Orozco-Díaz R; Sánchez-Álvarez A; Hernández-Hernández JM; Tapia-Ramírez J
    PLoS One; 2019; 14(7):e0220393. PubMed ID: 31361762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.
    Chen JY; Parekh M; Seliman H; Bakshinskaya D; Dai W; Kwan K; Chen KY; Liu AYC
    J Biol Chem; 2018 Oct; 293(40):15581-15593. PubMed ID: 30143534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein.
    Baldo B; Weiss A; Parker CN; Bibel M; Paganetti P; Kaupmann K
    J Biol Chem; 2012 Jan; 287(2):1406-14. PubMed ID: 22123826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19.
    He WT; Xue W; Gao YG; Hong JY; Yue HW; Jiang LL; Hu HY
    Sci Rep; 2017 Nov; 7(1):14797. PubMed ID: 29093475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
    Bithell A; Johnson R; Buckley NJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
    Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
    J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
    Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
    J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
    J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
    Chen GL; Ma Q; Goswami D; Shang J; Miller GM
    J Cell Mol Med; 2017 Nov; 21(11):2974-2984. PubMed ID: 28524599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.
    Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H
    Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of REST by Sp1 in Huntington's disease models.
    Ravache M; Weber C; Mérienne K; Trottier Y
    PLoS One; 2010 Dec; 5(12):e14311. PubMed ID: 21179468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
    Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
    Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington's disease cell models.
    Aravindan S; Chen S; Choudhry H; Molfetta C; Chen KY; Liu AYC
    Sci Rep; 2020 Sep; 10(1):15511. PubMed ID: 32968182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Conforti P; Cattaneo E; Buckley NJ
    J Neurochem; 2011 Feb; 116(3):415-25. PubMed ID: 21105876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
    Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I
    Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.